亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

臺州市源眾藥業有限責任公司  

公司專業從事高質量醫藥原料藥和中間體的研發、生產和銷售,產品主要涉及解毒類、健康營養類、抗真菌類、新材料、甾體激素類等領域,是國內唯一一家生產可降解塑料新材料的企業。

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:張佳
  • 電話:0576-87831166
  • 郵件:j.yojoy@hotmail.com
  • 傳真:0576-87831189
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 供應環戊內酯
供應環戊內酯
單價 面議對比
詢價 暫無
發貨 浙江臺州市付款后3天內
品牌 δ-戊內酯;delta-戊內酯;四氫-2H-2-吡喃酮;戊內酯
型號 542-28-9
過期 長期有效
更新 2012-08-02 13:04
 
詳細信息
             環戊內酯
  • ·產品類別:有機原料/酯類/有機酸酯類
  • ·英文名稱:Delta-Valerolactone
  • ·CAS NO:542-28-9
  • ·分子量:100.1158
  • ·EC NO:208-807-1
  • ·分子式:C5H8O2
  • ·InChI:InChI=1/C5H8O2/c6-5-3-1-2-4-7-5/h1-4H2
  • ·規格:1000kg/桶
  • ·產品介紹:品名:環戊內酯 CAS NO:542-28-9 外觀:無色至淡黃色透明液體酸度:≤1.0mgKOH/g 水分:≤0.15% 含量:≥98.0% 包裝規格:1000kg/桶
©2025 臺州市源眾藥業有限責任公司 版權所有   技術支持:化工網   訪問量:4566  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |